NCT03136159View on ClinicalTrials.gov

The Role of Antimicrobial Foam Dressing in Prevention of Cesarean Section Wound Complications

NACompletedINTERVENTIONAL

Enrollment

380

Participants

Timeline

Start Date

July 24, 2017

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions

Cesarean Section; Complications, Wound, Dehiscence

Interventions

DEVICE

Silver-impregnated antimicrobial dressing

All participants will receive an adherent soft silicone silver impregnated anti-microbial occlusive foam dressing after cesarean section. The dressing will stay on for up to seven days.

Trial Locations (1)

60153

Loyola University Medical Center, Maywood

All Listed Sponsors

collaborator

Molnlycke Health Care AB

INDUSTRY

lead

Loyola University

OTHER

NCT03136159 - The Role of Antimicrobial Foam Dressing in Prevention of Cesarean Section Wound Complications | Biotech Hunter | Biotech Hunter